Navigation Links
Sigma-Aldrich Announces Q4 2012 Earnings Conference Call
Date:1/23/2013

ST. LOUIS, Jan. 23, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) will hold its quarterly conference call to discuss fourth quarter and full-year 2012 results on Thursday, February 7, 2013, at 11:00 AM Eastern Time.

Conference call details:
Date: February 7, 2013
Time: 11:00 AM ET

Listen via Internet: http://investor.sigmaaldrich.com/
Telephone: 877-266-0483
International: 707-287-9342

A replay of the call will be available from 2/07/2013 to 2/14/2013. For replay, please call: Domestic: 855-859-2056 International: 404-537-3406; Conference ID#: 93187749.

About Sigma-Aldrich:  Sigma-Aldrich is a leading Life Science and High Technology company.  Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing.  The Company has customers in life science companies, university and government institutions, hospitals and industry.  Over one million scientists and technologists use its products.  Sigma-Aldrich operates in 38 countries and has 9,000 employees providing excellent service worldwide.  The Company is committed to accelerating customer success through innovation and leadership in Life Science, High Technology and Service.  For more information about Sigma-Aldrich, please visit its award winning web site at www.sigma-aldrich.com.

 


'/>"/>
SOURCE Sigma-Aldrich Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Sigma-Aldrich Elects Michael Marberry As Director
2. Sigma-Aldrich Corporation Announces New Credit Facility
3. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
4. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
5. Oramed Pharmaceuticals Announces Reverse Stock Split
6. Kenrico Announces Records of Patents for 2012 and Financial Targets for 2013
7. Cato Research and Cato BioVentures Announces the Opening of Houston, Texas, Office
8. PharmaDirections Announces Appointment of Dr. Bruce Rehlaender as Principal, Formulation Development
9. NSG Announces New Quartz Micro Flow Channel
10. Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
11. Inflamax Research announces the launch of its Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... England and SAN JOSE, California ... international biotechnology company developing antibody-drug conjugates for cancer, today announced ... Board of Directors. Dr Reynolds has over 20 years, development ... Medical Officer at Seattle Genetics. "I am delighted ...
(Date:1/15/2014)... 2014 More than 5 million Americans ... in 3 seniors will die with Alzheimer’s or another ... figures have shocked many Americans into looking for ways ... these tragic age-related cognitive disorders. Jonathan Weisman, president of ...
(Date:1/15/2014)... 2013 was a banner year of ... They saw continued independent research led by the team ... a $1 million grant from the Susanne Marcus Collins ... a peer reviewed journal, Amy Grant highlighted Brainwave Optimization® ...
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 , ... Club, 1360 Almshouse Road, Warrington, Pa. , Details: ... dedicated to finding a cure for hepatitis B and improving ... its annual Crystal Ball on Friday, April 11 at Warrington ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Danaher Corporation (NYSE:,DHR) announced that President and Chief ... at the J.P. Morgan Healthcare Conference in,San Francisco ... The audio will be,simultaneously webcast on http://www.danaher.com ... for one week., Danaher Corporation is ...
... THOR ), a world leader in products ... be participating in the JP,Morgan Healthcare Conference on ... chief executive officer, will provide an,update on the ... (11:30,a.m., Eastern Standard Time)., The presentation will ...
... than 500,000 Total Prescriptions Have Been Dispensed for ... ... 3 Shire plc (LSE: SHP,Nasdaq: SHPGY, TSX: SHQ), the ... from the U.S. Food and Drug,Administration (FDA) for three additional ...
Cached Biology Technology:FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 2FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 3FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 4FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 5
(Date:7/9/2014)... of increasing concern about the prevalence of antibiotic-resistant ... promising new pathway to disabling disease: blocking bacteria,s ... scientists showed how bacterial siderophore, a small molecule, ... fan bacterial growth as well as how ... infection process. Their findings appear in a recent ...
(Date:7/9/2014)... and fever but often can be defeated with antibiotics ... to beat. Now, scientists have built a new weapon against ... in the journal ACS Applied Materials & Interfaces , ... more of them than medicine alone. , David Leong, Jianping ... in wait, undetectable in the human body or in places ...
(Date:7/9/2014)... the amphibians with the highest distribution in the Iberian ... where it comes into contact with the red swamp ... by the Spaniard Germn Orizaola from the University of ... have developed a defensive response to the invasive species. ... they co-exist with the crayfish. , Numerous invasive organisms ...
Breaking Biology News(10 mins):Bacteria hijack plentiful iron supply source to flourish 2Frogs have developed rapid defences against the red swamp crayfish 2Frogs have developed rapid defences against the red swamp crayfish 3
... COLUMBIA, MO The American Association for the Advancement ... to Arun Chatterjee, a professor emeritus of plant sciences ... at the University of Missouri. Chatterjee was ... plant bacteriology, particularly for global regulation of virulence factors ...
... that the impact of disease-resistant genetically-modified wheat plants ... have looked at the effects of genetically-modified (GM) ... characterised by numerous insect species forming food webs. ... transgenic disease-resistant wheat lines and their effect on ...
... Madison, WI JANUARY 20, 2011 -- Chronic ... municipal wastewater, and atmospheric deposition from the burning of ... and harmful algal blooms. This nutrient pollution is prevalent ... Bay is the largest estuary in North America and ...
Cached Biology News:University of Missouri professor elected to American Association for the Advancement of Science 2New Anglo-Swiss research questions impact of GM wheat on insects 2Could oysters be used to clean up Chesapeake Bay? 2